Fight DiseaseAdvance Human Health

We drive breakthroughs in AI to tackle longstanding challenges in drug discovery

We combine these advances with experimental science and drug discovery expertise to create new medicines that make a meaningful difference for patients

Latest from Anew

September 19, 2026Tech Report

AnewDDE: An Agentic Drug Discovery Engine

An agentic drug discovery engine integrating structure prediction, molecular design, binding affinity, and scientific reasoning. Powered by experimental feedback, it enables closed-loop discovery for challenging therapeutic targets.

Platform

AnewFold

AnewFold

Accurate Structure Prediction for Proteins and Their Molecular Complexes

Learn More
AnewSampling

AnewSampling

A Scalable Dynamics-Aware AI Engine Reshapes Drug Discovery

AnewOmni

AnewOmni

Programming Biomolecular Interactions with All-Atom Generative Model

AnewDesign

AnewDesign

An Integrated Workflow for Antibody Design and Optimization

Learn More
AnewMind

AnewMind

A Scientific Reasoning LLM for Drug Discovery Decisions

Learn MoreComing Soon

Pipelines

Our integrated AI platform accelerates every stage of drug discovery, from target identification to clinical development.

Exploratory
Hit ID
Hit to Lead
Lead Optimization
IND Enabling

IL17AA/AF/FF

IL4R

Undisclosed Target 1

Undisclosed Target 2

Completed
In Progress
Planned

Teams

A Global Team. Built to Work as One.

With offices in Shanghai, San Francisco, and Singapore, we bring together expertise in AI and drug discovery from around the world.

We are building an organization where drug discovery experts and AI researchers work side by side—shaping the questions, developing the tools, and advancing new medicines together.

Global offices in Shanghai, San Francisco, and Singapore